Patients with Autoimmune Psychiatric Syndromes: Diagnostic and Treatment Experiences

Dominique Endres,Dominique Endres

DOI: https://doi.org/10.1016/j.psyneuen.2023.106775

IF: 4.693

2024-02-01

Psychoneuroendocrinology

Abstract:Background Autoimmune encephalitis caused by brain antibodies and presenting with isolated psychiatric symptoms has been increasingly observed recently. Most published cases involve autoimmune psychosis. Methods This presentation provides an overview of the typical clinical findings and first therapy experiences of these patients. In addition, new biomarkers—especially novel central nervous system (CNS) antibodies detected using tissue-based assays—will be addressed. Results Case reports and series have shown the importance of a multimodal diagnostic approach, including cerebrospinal fluid (CSF) analyses. An expansion of the clinical spectrum beyond autoimmune psychosis was recently observed, and the therapeutic experience of the first 91 cases from Germany is described (Endres et al., 2022, Molecular Psychiatry). In addition, an expanding spectrum of antibodies against different CNS structures (e.g., vessels, granule cells, myelin fibers, Purkinje cells, and astrocytes) was detected in the CSF of 119 patients with psychoses (Endres et al., 2022, Biological Psychiatry). Conclusion Autoantibody-associated autoimmune psychiatric syndromes probably affect only a small subgroup of patients. However, the clinical and antibody spectrum seems broader than initially thought. This could result in immunotherapeutic treatment approaches for patients with clear autoimmune psychiatric syndromes.

neurosciences,endocrinology & metabolism,psychiatry